AU2001280443A1 - Compositions and methods for the therapy and diagnosis of breast cancer - Google Patents

Compositions and methods for the therapy and diagnosis of breast cancer

Info

Publication number
AU2001280443A1
AU2001280443A1 AU2001280443A AU8044301A AU2001280443A1 AU 2001280443 A1 AU2001280443 A1 AU 2001280443A1 AU 2001280443 A AU2001280443 A AU 2001280443A AU 8044301 A AU8044301 A AU 8044301A AU 2001280443 A1 AU2001280443 A1 AU 2001280443A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280443A
Other languages
English (en)
Inventor
Davin C. Dillon
Susan L. Harlocker
Steven G Reed
Marc W. Retter
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/602,877 external-priority patent/US6432707B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001280443A1 publication Critical patent/AU2001280443A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001280443A 2000-06-22 2001-06-12 Compositions and methods for the therapy and diagnosis of breast cancer Abandoned AU2001280443A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/602,877 US6432707B1 (en) 1997-12-24 2000-06-22 Compositions and methods for the therapy and diagnosis of breast cancer
US09/602,877 2000-06-22
US68750700A 2000-10-12 2000-10-12
US09/687,507 2000-10-12
US77838101A 2001-02-06 2001-02-06
US09/778,381 2001-02-06
PCT/US2001/019032 WO2001098339A2 (fr) 2000-06-22 2001-06-12 Compositions et procedes de traitement et de diagnostic du cancer du sein

Publications (1)

Publication Number Publication Date
AU2001280443A1 true AU2001280443A1 (en) 2002-01-02

Family

ID=27416864

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280443A Abandoned AU2001280443A1 (en) 2000-06-22 2001-06-12 Compositions and methods for the therapy and diagnosis of breast cancer

Country Status (2)

Country Link
AU (1) AU2001280443A1 (fr)
WO (1) WO2001098339A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1777201A (en) * 1999-11-16 2001-05-30 Eos Biotechnology, Inc. Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators
EP2792747A1 (fr) * 2000-06-23 2014-10-22 Genentech, Inc. Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogenèse
CN100357320C (zh) * 2005-01-18 2007-12-26 北京大学 Zibc基因及其编码的蛋白和应用
CN100354302C (zh) * 2005-01-18 2007-12-12 北京大学 Sip基因及其编码的蛋白和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69737788T2 (de) * 1996-10-31 2008-03-13 Abbott Laboratories, Abbott Park Reagenzien und methoden zum nachweis von erkrankungen der brust
AU7180198A (en) * 1996-11-12 1998-06-03 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
CA2280229A1 (fr) * 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Gene 1 specifique du cancer du sein
CA2316397A1 (fr) * 1997-12-24 1999-07-08 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
ES2281416T3 (es) * 2000-04-03 2007-10-01 Corixa Corporation Metodos, composiciones y sistemas para la deteccion y monitorizacion del cancer de mama.

Also Published As

Publication number Publication date
WO2001098339A3 (fr) 2003-07-31
WO2001098339A2 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1515982A4 (fr) Methodes et compositions pour la therapie et le diagnostic du cancer de la prostate
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer